Shield Post-Approval Study Protocol

Clinical trial NCT06880055 · RECRUITING

Trial details

NCT number: NCT06880055
Sponsor: Guardant Health, Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

Colo-rectal Cancer

Start date: 2025-07-14
Primary completion: 2030-09-01
Enrollment: 3375

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.